FibroBiologics gets new U.S. patent covering fibroblast wound-healing therapy
FibroBiologics said a newly issued U.S. patent covers topical administration of 3D spheroid fibroblasts and fibroblast-derived materials to treat and accelerate healing of wounds.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.